The number of people with susceptibility test result for rifampicin in China
China: The number of people with susceptibility test result for rifampicin was 79.92 in 2021. ▲ Rising
Latest (2021)
79.92
Change on year
down 4.2%
World rank
95th
of 146 countries
All-time high
83.46
in 2020
All-time low
41.88
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in China, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in China stood at 79.92.
That represents a change of down 4.2% on the previous year and up 90.8% over five years.
That places China 95th out of 146 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in China, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 41.88 | — |
| 2018 | 57.85 | +38.1% |
| 2019 | 79.91 | +38.1% |
| 2020 | 83.46 | +4.4% |
| 2021 | 79.92 | -4.2% |
China compared with similar countries
- China's 79.92 is below the median for upper middle income countries, which is 92.7, 86% of the median. (45 countries reporting)
- China's 79.92 is below the median for East Asia & Pacific, which is 96.47, 83% of the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 59.88 | 41.88 | 79.91 | 3 |
| 2020s | 81.69 | 79.92 | 83.46 | 2 |
Countries ranked near China
More health data for China
- Un projection of annual infant deaths, annual growth rate -1.15 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.0985 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 2,029 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4,642 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 10 (2025)
- Population ages 00-04, female, annual growth rate -8.22 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0159 units per person (2025)
- Population ages 00-04, male, annual growth rate -8.73 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in China?
- The number of people with susceptibility test result for rifampicin in China was 79.92 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in China?
- The highest recorded value was 83.46 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in China?
- The lowest recorded value was 41.88 in 2017.
- How does China rank for the number of people with susceptibility test result for rifampicin?
- China ranks 95th out of 146 countries with data for 2021.
- Where does this China data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).